Defense Health Program
Department of Defense Lung Cancer Research Program Funding Opportunities for Fiscal Year 2012
The Fiscal Year 2012 (FY12) Defense Appropriations Act provides $10.2 Million (M) to the Department of Defense Lung Cancer Research Program’s (LCRP) to support innovative, high-impact lung cancer research. The LCRP is administered by the US Army Medical Research and Materiel Command (USAMRMC) through the Office of the Congressionally Directed Medical Research Programs (CDMRP).
The LCRP is providing the information in this pre-announcement to allow investigators time to plan and develop applications. FY12 LCRP Program Announcements and General Application Instructions for the following mechanisms are anticipated to be posted on Grants.gov in April 2012. Pre-application and application deadlines will be available when the Program Announcements are released. This pre-announcement should not be construed as an obligation by the government.
Investigators at all academic levels (or equivalent) Supports highly innovative, untested, potentially groundbreaking concepts in lung cancer. Emphasis in on innovation. Presentation of preliminary data is not consistent with the intent of the Concept Award mechanism and is discouraged. Human subject studies are permitted provided the studies are exempt or eligible for expedited review. Maximum funding of $100K for direct costs (plus indirect costs). Maximum period of performance is 1 year.
Idea Development Award
Independent investigators at or above the level of an Assistance Professor (or equivalent); must be within 10 years of first faculty appointment. Supports new ideas that are in the early stages of development which represent innovative, high-risk/high-gain approaches to lung cancer research. Emphasis is on Innovation and Impact. Preliminary data required, but may be from outside of lung cancer. Clinical trials are not allowed. Maximum funding of $350K for direct costs (plus indirect costs). Maximum period of performance is 2 years.
Translational Research Partnership Award Investigators at or above the level of Assistant Professor (or equivalent). Supports partnerships between clinicians and laboratory scientists that accelerate ideas in lung cancer into clinical applications. Preliminary data required, but may be from outside of lung cancer. Clinical trials are not allowed. Non-Traditional Partnerships are encouraged. Optional Nested Clinical Fellow or Resident Traineeship. Maximum combined funding of $900K for direct costs (plus indirect costs). Maximum period of performance is 3 years. Nested traineeships: Additional maximum of $75K in direct and indirect costs over a one-year period of performance.
All applications must conform to the final Program Announcements and application instructions that will be available for electronic downloading from the Grants.gov website. The applications package containing the required forms for each award mechanism will also be found on Grants.gov. A listing of all USAMRMC funding opportunities can be obtained on the Grants.gov website by performing a basic search using CFDA Number 12.420.
A pre-application is required and must be submitted through the CDMRP eReceipt website (http://cdmrp.org) prior to the pre-application deadline. Applications must be submitted through the federal government’s single-entry portal, Grants.gov. Submission deadlines are not available until the Program Announcements are released.
Requests for email notification of the Program Announcements release may be sent to email@example.com. Email notifications of funding opportunities are sent as a courtesy and should not be used as a sole source of notification; applicants should monitor Grants.gov for official postings of funding opportunities.
For more information about the LCRP or other CDMRP-sponsored programs, please visit the CDMRP website (http://cdmrp.army.mil).
Point of Contact :DMRP Public Affairs 301-619-9783
Related topics: grant